Positively selected genes with a role in immunomodulation and/or virulence.
Gene . | OPG . | Sitesa . | Features and function . | References . |
---|---|---|---|---|
A37R | OPG163 | V46A/I | A deletion mutant is highly attenuated in the intranasal and intraperitoneal mouse challenge models; inhibits MHC Class II-restricted antigen presentation | Rehm et al. (2010); Roper (2006) |
A43R | OPG172 | A126V | Putative Type I membrane protein; a deletion mutant produces significantly smaller lesions than the control in the skin of mice | Sood and Moss (2010) |
B4R | OPG188 | V265I S419R | Poxin; cleaves 2′3′ cGAMP to restrict STING-dependent signaling | Eaglesham et al. (2019) |
B5R | OPG189 | K185 R R506H/C | ANK repeat- and PRANC domain-containing protein; an ectromelia virus deletion mutant showed decreased spread to organs and was attenuated during mouse infection | Burles et al. (2014) |
B8R | OPG192 | G100E | Endoplasmic reticulum resident protein; a deletion mutant is attenuated in a murine intradermal model (smaller lesions than the control virus) | Price et al. (2000) |
B13 R | OPG200 | D52G E134G | Cytosolic virulence factor; inhibits IκB kinase | Chen, Jacobs, and Smith (2006); Chen et al. (2008) |
B20R | OPG209 | I11V L21F | TNF receptor | Chen et al. (2005) |
B21R | OPG210 | A98D V173I N334I E1862D | Inhibits TCR-mediated stimulation; deletion reduces virulence in a non-human primate model | Alzhanova et al. (2014) |
C6R | OPG044 | T109A | Virulence factor that inhibits DDX3 | Schröder, Baran, and Bowie (2008) |
D13 L | OPG031 | T80M C241Y | Inactivates DNA sensing and enhances virulence by binding Ku | Rivera-Calzada et al. (2022) |
F3L | OPG065 | A17T H61N | Competes with ZBP1 for Z-DNA binding; blocks necroptosis | Koehler et al. (2021) |
G7R | OPG091 | V62I S73N | Enzyme activity; deletion, or catalytically inactive mutants cause less severe disease in mice than WT viruses | Senkevich et al. (2008) |
J3L/J1Rb | OPG003 | A188V D488N | ANK repeat and F-box containing protein; targets RIPK3 for degradation and inhibits necroptosis | Liu et al. (2021) |
N3R | OPG016 | E80V | Secreted protein; functions as a competitive antagonist of the NKG2D activating receptor | Campbell et al. (2007) |
O1L | OPG037 | C144Y | ANK repeat containing protein; prevents apoptotic functions of the apoptosome | Ryerson et al. (2017) |
Gene . | OPG . | Sitesa . | Features and function . | References . |
---|---|---|---|---|
A37R | OPG163 | V46A/I | A deletion mutant is highly attenuated in the intranasal and intraperitoneal mouse challenge models; inhibits MHC Class II-restricted antigen presentation | Rehm et al. (2010); Roper (2006) |
A43R | OPG172 | A126V | Putative Type I membrane protein; a deletion mutant produces significantly smaller lesions than the control in the skin of mice | Sood and Moss (2010) |
B4R | OPG188 | V265I S419R | Poxin; cleaves 2′3′ cGAMP to restrict STING-dependent signaling | Eaglesham et al. (2019) |
B5R | OPG189 | K185 R R506H/C | ANK repeat- and PRANC domain-containing protein; an ectromelia virus deletion mutant showed decreased spread to organs and was attenuated during mouse infection | Burles et al. (2014) |
B8R | OPG192 | G100E | Endoplasmic reticulum resident protein; a deletion mutant is attenuated in a murine intradermal model (smaller lesions than the control virus) | Price et al. (2000) |
B13 R | OPG200 | D52G E134G | Cytosolic virulence factor; inhibits IκB kinase | Chen, Jacobs, and Smith (2006); Chen et al. (2008) |
B20R | OPG209 | I11V L21F | TNF receptor | Chen et al. (2005) |
B21R | OPG210 | A98D V173I N334I E1862D | Inhibits TCR-mediated stimulation; deletion reduces virulence in a non-human primate model | Alzhanova et al. (2014) |
C6R | OPG044 | T109A | Virulence factor that inhibits DDX3 | Schröder, Baran, and Bowie (2008) |
D13 L | OPG031 | T80M C241Y | Inactivates DNA sensing and enhances virulence by binding Ku | Rivera-Calzada et al. (2022) |
F3L | OPG065 | A17T H61N | Competes with ZBP1 for Z-DNA binding; blocks necroptosis | Koehler et al. (2021) |
G7R | OPG091 | V62I S73N | Enzyme activity; deletion, or catalytically inactive mutants cause less severe disease in mice than WT viruses | Senkevich et al. (2008) |
J3L/J1Rb | OPG003 | A188V D488N | ANK repeat and F-box containing protein; targets RIPK3 for degradation and inhibits necroptosis | Liu et al. (2021) |
N3R | OPG016 | E80V | Secreted protein; functions as a competitive antagonist of the NKG2D activating receptor | Campbell et al. (2007) |
O1L | OPG037 | C144Y | ANK repeat containing protein; prevents apoptotic functions of the apoptosome | Ryerson et al. (2017) |
Notes: aAmino acid positions refer to MPXV NC_003310 (Zaire-96-I-16).
Paralog genes located in the ITR.
Positively selected genes with a role in immunomodulation and/or virulence.
Gene . | OPG . | Sitesa . | Features and function . | References . |
---|---|---|---|---|
A37R | OPG163 | V46A/I | A deletion mutant is highly attenuated in the intranasal and intraperitoneal mouse challenge models; inhibits MHC Class II-restricted antigen presentation | Rehm et al. (2010); Roper (2006) |
A43R | OPG172 | A126V | Putative Type I membrane protein; a deletion mutant produces significantly smaller lesions than the control in the skin of mice | Sood and Moss (2010) |
B4R | OPG188 | V265I S419R | Poxin; cleaves 2′3′ cGAMP to restrict STING-dependent signaling | Eaglesham et al. (2019) |
B5R | OPG189 | K185 R R506H/C | ANK repeat- and PRANC domain-containing protein; an ectromelia virus deletion mutant showed decreased spread to organs and was attenuated during mouse infection | Burles et al. (2014) |
B8R | OPG192 | G100E | Endoplasmic reticulum resident protein; a deletion mutant is attenuated in a murine intradermal model (smaller lesions than the control virus) | Price et al. (2000) |
B13 R | OPG200 | D52G E134G | Cytosolic virulence factor; inhibits IκB kinase | Chen, Jacobs, and Smith (2006); Chen et al. (2008) |
B20R | OPG209 | I11V L21F | TNF receptor | Chen et al. (2005) |
B21R | OPG210 | A98D V173I N334I E1862D | Inhibits TCR-mediated stimulation; deletion reduces virulence in a non-human primate model | Alzhanova et al. (2014) |
C6R | OPG044 | T109A | Virulence factor that inhibits DDX3 | Schröder, Baran, and Bowie (2008) |
D13 L | OPG031 | T80M C241Y | Inactivates DNA sensing and enhances virulence by binding Ku | Rivera-Calzada et al. (2022) |
F3L | OPG065 | A17T H61N | Competes with ZBP1 for Z-DNA binding; blocks necroptosis | Koehler et al. (2021) |
G7R | OPG091 | V62I S73N | Enzyme activity; deletion, or catalytically inactive mutants cause less severe disease in mice than WT viruses | Senkevich et al. (2008) |
J3L/J1Rb | OPG003 | A188V D488N | ANK repeat and F-box containing protein; targets RIPK3 for degradation and inhibits necroptosis | Liu et al. (2021) |
N3R | OPG016 | E80V | Secreted protein; functions as a competitive antagonist of the NKG2D activating receptor | Campbell et al. (2007) |
O1L | OPG037 | C144Y | ANK repeat containing protein; prevents apoptotic functions of the apoptosome | Ryerson et al. (2017) |
Gene . | OPG . | Sitesa . | Features and function . | References . |
---|---|---|---|---|
A37R | OPG163 | V46A/I | A deletion mutant is highly attenuated in the intranasal and intraperitoneal mouse challenge models; inhibits MHC Class II-restricted antigen presentation | Rehm et al. (2010); Roper (2006) |
A43R | OPG172 | A126V | Putative Type I membrane protein; a deletion mutant produces significantly smaller lesions than the control in the skin of mice | Sood and Moss (2010) |
B4R | OPG188 | V265I S419R | Poxin; cleaves 2′3′ cGAMP to restrict STING-dependent signaling | Eaglesham et al. (2019) |
B5R | OPG189 | K185 R R506H/C | ANK repeat- and PRANC domain-containing protein; an ectromelia virus deletion mutant showed decreased spread to organs and was attenuated during mouse infection | Burles et al. (2014) |
B8R | OPG192 | G100E | Endoplasmic reticulum resident protein; a deletion mutant is attenuated in a murine intradermal model (smaller lesions than the control virus) | Price et al. (2000) |
B13 R | OPG200 | D52G E134G | Cytosolic virulence factor; inhibits IκB kinase | Chen, Jacobs, and Smith (2006); Chen et al. (2008) |
B20R | OPG209 | I11V L21F | TNF receptor | Chen et al. (2005) |
B21R | OPG210 | A98D V173I N334I E1862D | Inhibits TCR-mediated stimulation; deletion reduces virulence in a non-human primate model | Alzhanova et al. (2014) |
C6R | OPG044 | T109A | Virulence factor that inhibits DDX3 | Schröder, Baran, and Bowie (2008) |
D13 L | OPG031 | T80M C241Y | Inactivates DNA sensing and enhances virulence by binding Ku | Rivera-Calzada et al. (2022) |
F3L | OPG065 | A17T H61N | Competes with ZBP1 for Z-DNA binding; blocks necroptosis | Koehler et al. (2021) |
G7R | OPG091 | V62I S73N | Enzyme activity; deletion, or catalytically inactive mutants cause less severe disease in mice than WT viruses | Senkevich et al. (2008) |
J3L/J1Rb | OPG003 | A188V D488N | ANK repeat and F-box containing protein; targets RIPK3 for degradation and inhibits necroptosis | Liu et al. (2021) |
N3R | OPG016 | E80V | Secreted protein; functions as a competitive antagonist of the NKG2D activating receptor | Campbell et al. (2007) |
O1L | OPG037 | C144Y | ANK repeat containing protein; prevents apoptotic functions of the apoptosome | Ryerson et al. (2017) |
Notes: aAmino acid positions refer to MPXV NC_003310 (Zaire-96-I-16).
Paralog genes located in the ITR.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.